Results

Total Results: 3,179 records

Showing results for "medication".
Users also searched for: medication reconciliation

  1. Layout 1 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/antipsychotics-children_executive.pdf
    February 01, 2012 - In general, the choice of medication in children and adolescents is often driven by side-effect profiles … Do FGAs and SGAs differ in medication-associated adverse events when used in children, youth, and young … • Medication adherence and persistence. • School performance and attendance. … Schizophrenia Medication adherence FGA vs. SGA (2 RCT, 1 PCS) Low No significant difference. … A three-country comparison of psychotropic medication prevalence in youth.
  2. effectivehealthcare-admin.ahrq.gov/products/nursing-home-safety/research-protocol
    December 01, 2019 - outcomes align with the most common reasons for NH litigation (falls, pressure ulcers, weight loss, medication … on Nursing Home Safety version 0.1 Beta. 10 These include: falls, healthcare-associated infection, medicationMedication error and adverse drug events Common Format/ Nursing Home Compare QI Medication management … Nursing Home Compare QI Medication management, staff education and training Moderate to severe … pain Nursing Home Compare QI Staffing changes, staff education, medication management Influenza
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1406.pdf
    June 01, 2014 - The patient ingests the medication along with the sensor, and digestive fluids activate the sensor … Lack of patient adherence to the medication regimens tested in clinical trials has been implicated … Thus, whether this would add to overall costs or offset costs of nonadherence to medication regimens … among experts about this technology’s potential to improve medication adherence and health outcomes … Medication adherence was >85%.
  4. effectivehealthcare-admin.ahrq.gov/products/childhood-depression/research
    March 01, 2022 - management Continued medication management 1 46 RR: 0.36; 95% CI: 0.11 to 1.17 insufficient Remission … management Continued medication management 1 46 RR: 0.55; 95% CI: 0.05 to 5.60 insufficient Suicidal … management Continued medication management 1 46 RR: 0.36; 95% CI: 0.02 to 8.46 insufficient Dropout … management Continued medication management 1 144 RR: 0.13; 95% CI: 0.01 to 2.50 insufficient Suicidal … management Continued medication management 1 144 RR: 0.31; 95% CI: 0.01 to 7.41 insufficient Suicide
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_june_2012.pdf
    January 01, 2012 - Overall High Impact Potential: Intelligent pills to monitor patient medication use .............. 6 … *Intelligent pills (Raisin System ) to monitor patient medication adherence Moderately high 4. …  Potential for High Impact: High Intelligent Pills to Monitor Patient Medication Adherence … Medication adherence was >85%. … on the way the medication is prescribed, not necessarily on the way it is actually taken.
  6. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - These studies compared the use of long tolerated innovator antiepileptic medication with short-term … As such, the switchback from a generic to an innovator antiepileptic medication may or may not be due … New Evidence: Switching from an innovator to a generic antiepileptic medication … These studies compared the use of long tolerated innovator antiepileptic medication with short-term … New Evidence: While data on BCS class for the innovator versus generic antiepileptic medication
  7. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/epilepsy-medicine_surveillance.pdf
    August 01, 2012 - These studies compared the use of long tolerated innovator antiepileptic medication with short-term … As such, the switchback from a generic to an innovator antiepileptic medication may or may not be due … New Evidence: Switching from an innovator to a generic antiepileptic medication … These studies compared the use of long tolerated innovator antiepileptic medication with short-term … New Evidence: While data on BCS class for the innovator versus generic antiepileptic medication
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting_hi_impact.pdf
    January 01, 2012 - Overall High Impact Potential: Intelligent pills to monitor patient medication use .............. 3 … *Intelligent pills to monitor patient medication use 3. … Medication adherence was >85%. … As one commentator who is a pharmacist stated, “Clinicians might alter or change a medication based … on the way the medication is prescribed, not necessarily on the way it is actually taken.
  9. S66 (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/s66.pdf
    October 01, 2007 - In this situation, the new episode of use started on the date the new medication was filled. … MPR indicates medication possession ratio. … Adherence to medication. N Engl J Med. 2005;353:487–497. 19. … The language of medication-taking. Ann Intern Med. 2000;132:926–930. 21. … Evaluating medication effects outside of clinical trials: new- user designs.
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/alcohol-misuse-drug-therapy_clinician.pdf
    February 01, 2016 - Head-to-head trials have not consistently established the superiority of one medication over another … Factors that may guide medication choices include frequency of administration, dosing schedule or other … Medication Outcome N Studiesa N Subjects Finding Effect Size (95% CI) NNTb SOE Acamprosate vs. placebo … b This medication has not been approved by the FDA for the treatment of alcohol dependence, alcohol … In most studies, patients abstained for at least 3 days before starting medication.
  11. Politi (pdf file)

    effectivehealthcare-admin.ahrq.gov/sites/default/files/politi.pdf
    December 26, 2012 - Decisions: • BCS vs. mastectomy for average risk patients with early stage breast cancer • Diabetes medication … • Stochastic Uncertainty • Frequencies (or percentages) Pictographs Example: MD discussing BP  medication … About 2 out of 100 patients who take this medication will develop low blood pressure. … What not to do: 2 out of 10 patients who  take this medication  could  develop low blood  pressure
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1506.pdf
    June 01, 2015 - The patient ingests the medication along with the sensor, and digestive fluids activate the sensor … Lack of patient adherence to medication regimens tested in clinical trials has been implicated as a … Thus, whether this will add to overall costs or offset costs of nonadherence to medication regimens … Medication adherence was >85%. … Proteus promotes medication adherence using ingestible sensors. Gray Sheet. 2012 Aug 6. 20.
  13. effectivehealthcare-admin.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1512.pdf
    December 01, 2015 - The patient ingests the medication along with the sensor, and digestive fluids activate the sensor … Lack of patient adherence to medication regimens tested in clinical trials has been implicated as a … Whether this will add to overall costs or offset costs of nonadherence to medication regimens is not … or into the active medication itself.2,4,5 The technology’s manufacturer states that the sensor is … Medication adherence was >85%.
  14. effectivehealthcare-admin.ahrq.gov/health-topics/elderly
    February 01, 2024 - Products Rapid Evidence Product February 1, 2024 Deprescribing To Reduce Medication … Research Protocol September 5, 2023 Making Healthcare Safer IV: Deprescribing to Reduce Medication
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-2.pdf
    June 01, 2022 - ; (4) dose of medication; (5) duration of treatment? … ; (4) dose of medication; (5) the duration of therapy? … *" or "neuromuscular drug*" or "neuromuscular medication*" or "neuromuscular nondepolarizing agent*" … *" or "neuromuscular drug*" or "neuromuscular medication*" or "neuromuscular nondepolarizing agent*" … Acute migraine medication and medication overuse headache: a systematic literature review.
  16. effectivehealthcare-admin.ahrq.gov/products/dementia-databases-methods/research
    January 01, 2020 - Medication use was derived from self-reports (community) and extracts of facility medication administration … Medication measures included the cholinesterase inhibitors, donepezil, galantamine, and rivastigmine … Medication use was derived from self-reports (community) and extracts of facility medication administration … Respondents are asked to keep all medication containers which are reviewed by the interviewer during … facility's monthly Medication Administration records (MAR).
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/15_crosscutting_potential_high_impact_2012-12-11.pdf
    January 01, 2012 - Overall high-impact potential: intelligent pills (The Raisin System) to monitor patient medication … (wound care, medication reconciliation), prevention (immunizations, fall assessment), and referral … Medication adherence was >85%. … HS262 - Intelligent pills (Raisin System) to monitor patient medication use in chronic diseases. … HS262 - Intelligent pills (Raisin System) to monitor patient medication use in chronic diseases.
  18. effectivehealthcare-admin.ahrq.gov/products/renal-disease-therapies/abstract
    December 01, 2019 - We will model the association between antihypertensive medication use and outcomes using various longitudinal … Analyses will adjust for potential confounders of the relation between antihypertensive medication and … dependent variables, and we will also account for the interaction between each class of antihypertensive medication
  19. effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/for-adult-patients-with-bipolar-disorder-including-bipolar-i-and-bipolar-ii-disorder-what-is-the-comparative-effectiveness-of-available-treatments-including-psychotherapy-other-psychosocial-treatments-medications-and-other-s
    November 01, 2017 - treatment of a manic episode following inadequate response: Addition of another mood-stabilizing medication … vs. placebo vs. switch to a different mood-stabilizing medication vs. switch to ECT For treatment … ECT Antidepressant monotherapy vs. any mood-stabilizing medication For treatment of a depressive … e.g., motivational enhancement, behavioral, or cognitive behavioral) vs. treatment with maintenance medication … Addition of pharmacotherapy targeting the substance use disorder(s) vs. treatment with maintenance medication
  20. effectivehealthcare-admin.ahrq.gov/products/asthma-immunotherapy/research-protocol
    April 01, 2021 - use Asthma specific medication use (name, dose, duration) Long-term controller medication use … Quick relief medication use Systemic corticosteroids for asthma Asthma exacerbations / Healthcare … Medications Definition of medication purpose Long-term controller medications: They should be taken … Asthma Medication use: Need of daily medications. … Reduction in long-term controller medication and quick relief medication.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: